Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • Drug Charts
    • Do Not Crush List
    • New Drugs
    • Original Container Meds
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Psychiatry
  4. Depression
  5. Drugs
  6. TCAs

TCAs

  • ADHD (51)
  • Anxiety (27)
  • Bipolar Disorder (12)
  • Depression (184)
    • Cardiovascular Disease and Depression (4)
    • Drugs (161)
      • Atypical Antipsychotics (49)
      • Benzodiazepines (31)
      • Bupropion (34)
      • MAOIs (10)
      • SNRIs (69)
      • SSRIs (90)
      • TCAs (33)
      • Typical Antipsychotics (2)
    • Natural Medicines/Supplements (9)
    • Pediatrics (13)
    • Post-Traumatic Stress Disorder (9)
    • Pregnancy (7)
    • Seasonal Affective Disorder (5)
    • Treatment-Resistant Depression (16)
  • Mental Health (25)
  • Resources (108)
  • Schizophrenia (45)
  • Sleep Disorders (67)
  • Substance Use Disorder (156)
16 - 30 of 33 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Drugs Associated with Weight Gain May 2015
Article: Include an "Avoid Alcohol" Warning Label on Opioid Rxs December 2014
Commentary: SSRIs and SNRIs and Bleeding Risk: Focus on Drug Interactions November 2014
Other: Controlled Substances: Keeping Patients Safe and Preventing Diversion February 2014
Commentary: Pharmacotherapy of Pediatric Anxiety January 2014
Chart: Comparison of Antidepressants December 2013
Commentary: Treatment-Resistant Depression September 2013
Article: keep all the meds used for anxiety in children straight May 2013
Article: Silenor (SI-leh-nor) is a NEW formulation of doxepin for insomnia May 2013
Chart: Pharmacotherapy of Fibromyalgia December 2012
Article: more emphasis on treating fibromyalgia December 2012
Patient Education: Safe Use of Acetaminophen (Tylenol) August 2011
Guideline: Practice Guideline for the Treatment of Patients With Major Depressive Disorder (2010) November 2010
Commentary: Depression Guidelines: Overview of Pharmacotherapy November 2010
Commentary: Oleptro (Trazodone) and Silenor (Doxepin) October 2010
  • « Prev
  • 1
  • 2
  • 3
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved